Lido Advisors LLC increased its stake in Integer Holdings Corporation (NYSE:ITGR – Free Report) by 752.0% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 24,597 shares of the medical equipment provider’s stock after buying an additional 21,710 shares during the quarter. Lido Advisors LLC’s holdings in Integer were worth $2,165,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ITGR. Irenic Capital Management LP bought a new stake in Integer in the fourth quarter worth $99,109,000. Alliancebernstein L.P. increased its holdings in shares of Integer by 885.1% during the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock valued at $136,016,000 after acquiring an additional 993,810 shares in the last quarter. Millennium Management LLC raised its position in shares of Integer by 3,350.2% in the 4th quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock worth $53,106,000 after purchasing an additional 657,483 shares during the last quarter. J. Goldman & Co LP purchased a new position in shares of Integer in the 4th quarter worth about $40,531,000. Finally, The Manufacturers Life Insurance Company boosted its stake in Integer by 168.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 704,600 shares of the medical equipment provider’s stock worth $55,262,000 after purchasing an additional 442,355 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.
Wall Street Analysts Forecast Growth
ITGR has been the subject of a number of analyst reports. Citigroup raised their price objective on shares of Integer from $92.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Zacks Research upgraded shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. KeyCorp reiterated an “overweight” rating and set a $104.00 price target on shares of Integer in a report on Tuesday, July 21st. Truist Financial raised their price target on shares of Integer from $97.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, July 16th. Finally, Freedom Capital upgraded shares of Integer to a “strong-buy” rating in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $97.00.
Integer Stock Performance
Shares of ITGR stock opened at $98.61 on Monday. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. The company has a 50 day moving average price of $92.47 and a 200-day moving average price of $88.22. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $111.99. The firm has a market capitalization of $3.35 billion, a PE ratio of 24.59, a P/E/G ratio of 2.35 and a beta of 0.64.
Integer (NYSE:ITGR – Get Free Report) last issued its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.21 by ($0.01). Integer had a return on equity of 12.83% and a net margin of 7.64%.The company had revenue of $439.58 million during the quarter, compared to analysts’ expectations of $426.48 million. During the same quarter in the prior year, the business posted $1.31 EPS. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities research analysts expect that Integer Holdings Corporation will post 6.04 earnings per share for the current year.
About Integer
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Featured Stories
- Five stocks we like better than Integer
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR – Free Report).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
